My Sisters Place

What the SAMHSA Record Shows About My Sisters Place

My Sisters Place is a substance use treatment operated by Private non-profit organization in Philadelphia, Pennsylvania. The facility's N-SUMHSS record lists 2 primary care modalities (residential, telehealth), which shapes both how treatment is delivered and how intake is scheduled. Medication-Assisted Treatment (MAT) is reported as available, meaning FDA-approved medications such as methadone, buprenorphine, or naltrexone may be combined with counseling for opioid or alcohol use disorder. The full postal address on file is 1239 Spring Garden Street, Philadelphia, PA 19123.

On the services side, the facility self-reports 10 distinct service lines (12-step facilitation, Cognitive behavioral therapy, Medication-assisted treatment (MAT), Mental health services, Motivational interviewing, Residential, Substance use treatment, Suicide prevention services, Telehealth, Trauma-informed care), 3 substance or condition categories treated (Alcohol, General substance use disorders, Opioids), and 11 clinical treatment approaches (12-step facilitation, Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Matrix Model, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy, Trauma-related counseling). It serves 13 specific population groups (Adults, Justice-involved individuals, Persons affected by intimate partner violence, Persons who have experienced sexual abuse, Persons who have experienced trauma, Persons with DUI/DWI, Persons with HIV/AIDS, Persons with co-occurring disorders, Persons with co-occurring pain, Pregnant or postpartum individuals, Veterans, Women, Young adults) with 1 language of care (Sign language services for the deaf and hard of hearing). Those figures give a rough signal of programmatic breadth, a higher number of approaches and populations usually indicates more structured clinical programming rather than a single-modality operation. Payment-wise, the record confirms Medicaid, plus 5 specific payment methods enumerated in the survey (Cash or self-payment, Federal, or any government funding for substance use treatment programs, Medicaid, SAMHSA funding/block grants, State-financed health insurance plan other than Medicaid).

This record is one of the more thoroughly documented substance use treatment listings in Pennsylvania: it reports 44 distinct service, population, payment, and language attributes, placing it in the top 9% of 757 facilities statewide (state median: 32). More attributes reported generally means more of your specific questions (payment type, language, care setting) are answered before you call.

Use this page as a starting screen, not a final decision. SAMHSA fields are self-reported by the facility and refreshed on a rolling basis, so wait times, bed availability, current insurance contracts, and staff credentials are best confirmed on a direct intake call to (215) 955-3792. This page is a factual directory summary, not medical advice, clinical endorsement, or a guarantee of admission. For any acute crisis or active substance-use emergency, call the SAMHSA National Helpline at 1-800-662-4357 or the 988 Suicide & Crisis Lifeline before visiting any facility.